PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
30-Sep-2024 DARZALEX® (daratumumab) subcutaneous (SC) formulation-based quadruplet regimen significantly improves minimal residual disease negativity for newly diagnosed multiple myeloma patients for whom transplant is not planned Janssen-Cilag
30-Sep-2024 Global AMR Challenge Receives a £5m Boost to Drive Diagnostics Innovation PACE
30-Sep-2024 COVID's 'Hidden Figure' Addresses 'Techanthropy' and Small Business Challenges in New Product and National Column AccessWire
30-Sep-2024 Gerresheimer AG: Adjustment of growth guidance for 2024 and 2025 Gerresheimer AG
30-Sep-2024 Revolutionizing Med Spa Excellence: Academy of Aesthetics Offers Top-Tier Medical Director Services and Private Training for Injectors AccessWire
30-Sep-2024 Hypha Labs, Inc. Reveals First Functional Mushroom Ingredient Array for Home and Commercial Production AccessWire
30-Sep-2024 Axis Integrated Mental Health Recognized as Top Startup for Advancing Collaborative Mental Health Care AccessWire
30-Sep-2024 Study Indicates Significant Radiation Reduction for Breast Cancer Patients AccessWire
30-Sep-2024 Decoding the Phases of Clinical Trials: From Concept to Market Fusion technology solutions
30-Sep-2024 Modular Medical to Present at the Lytham Partners Fall 2024 Investor Conference on October 1 AccessWire
30-Sep-2024 Advanced Wound Care Market Grows Rapidly: Demand for Innovative Therapies on the Rise Pristine Market Insights
30-Sep-2024 Anticancer Drugs Market Growth Fueled by Advancements in Personalized Medicine Pristine Market Insights
30-Sep-2024 Global Disposable Contact Lenses Market: Trends, Opportunities and Future Projections Pristine Market Insights
30-Sep-2024 Tharimmune Signs Nonbinding Letter of Intent to Merge With Intract Pharma to Create Transformative Oral Biologic Therapeutics Company Newswire
30-Sep-2024 Tharimmune Signs Nonbinding Letter of Intent to Merge With Intract Pharma to Create Transformative Oral Biologic Therapeutics Company AccessWire
30-Sep-2024 Moderna Announces First Participant Dosed in Pivotal Phase 3 Trial of Investigational mRNA Norovirus Vaccine, mRNA-1403 AccessWire
30-Sep-2024 Array Instruments Market Trends & Drivers: Shaping the Future of Diagnostics and Research Pristine Market Insights
30-Sep-2024 NanoViricides, Inc. Has Filed its Annual Report: Broad-spectrum Antiviral NV-387 Progressing to Phase II Clinical Trial - Multiple Indications of NV-387 Include RSV, Influenza, MPOX/Smallpox, COVID AccessWire
30-Sep-2024 Clinical Thermometry Market: Emerging Trends, Key Drivers and Future Opportunities Pristine Market Insights
30-Sep-2024 Cardiovascular Diagnostics Market Poised for Significant Growth Amidst Increasing Prevalence of Heart Diseases Pristine Market Insights